Belite Bio CFO Chuang Hao-Yuan sells $66,187 in shares By Investing.com

Chuang Hao-Yuan, the Chief Financial Officer and a Director at BELITE BIO, INC (), sold American depositary shares totaling $66,187 on August 12, 2026.

The transactions involved the sale of 367 American depositary shares at prices ranging from $180.00 to $180.57 per share. Following these sales, Mr. Chuang directly holds 93,433 American depositary shares in the company. The sale came after BLTE’s remarkable 141% return over the past year, though the stock has since pulled back to $166.28. According to InvestingPro analysis, the stock remains undervalued despite its strong run, with 14 additional ProTips available to subscribers. Each American depositary share represents one ordinary share of BELITE BIO, INC.

The reported sales were executed pursuant to a Rule 10b5-1 trading plan, which Mr. Chuang adopted on December 22, 2025.

In other recent news, Belite Bio reported its second-quarter 2026 financial results, showing a smaller-than-expected loss. The company posted an adjusted earnings per share (EPS) of -$0.54, surpassing analyst expectations of -$0.7525. This marks a 28.24% improvement over the anticipated figures. Despite the better-than-expected EPS, Belite Bio’s revenue was not meaningful during this period. The company continues to operate without product revenue, which remains a significant point of focus for investors. Additionally, there were no significant mergers or acquisitions announced. Analyst firms have yet to provide new upgrades or downgrades following the earnings report. These developments reflect the current state of the company as it navigates its financial landscape.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.